https://www.selleckchem.com/pr....oducts/ly3537982.htm
PDC is feasible with low mortality and is associated with manageable complication rates. 5-year survival of patients undergoing PDC with MCR in multi-modality setting is approaching 25% depending on quantitative and clinical stage, **** and histological subtype and is better than PDC without- MCR. PDC is feasible with low mortality and is associated with manageable complication rates. 5-year survival of patients undergoing PDC with MCR in multi-modality setting is approaching 25% depending on quantitative and clinical stage, **** and hi
Like
Comment
Share
